Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation?
Henry Shen, Joanne Lundy, Andrew Strickland, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3175-3175
Open Access | Times Cited: 25

Showing 25 citing articles:

Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 126
The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma
Faria Nusrat, Akshay Khanna, Aditi Jain, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2103-2103
Open Access | Times Cited: 9
In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches
Amar Ajmal, Muhammad Danial, Maryam Zulfat, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 551-551
Open Access | Times Cited: 6
Advancements in Preclinical Models of Pancreatic Cancer
P Salu, Katie M. Reindl
Pancreas (2024) Vol. 53, Iss. 2, pp. e205-e220
Closed Access | Times Cited: 5
Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy
Olamide Tosin Olaoba, Temitope Isaac Adelusi, Ming Yang, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1808-1808
Open Access | Times Cited: 5
Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Clinical Cancer Research (2025)
Open Access
Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways
Hnin Ei Ei Khine, Utid Suriya, Thanyada Rungrotmongkol, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hybrid-Free DNA Test by Band Engineering of Nitride Semiconductor and Machine Learning
Thi Anh Nguyet Nguyen, Fan‐Ching Chien, Khanh Huynh Thuy Doan, et al.
ACS Applied Electronic Materials (2025)
Open Access
Zehn Jahre Molekulares Tumorboard: von der Genomsequenzierung zur personalisierten Krebstherapie
Benedikt Färber, Jan Morf, Jan Vorwerk, et al.
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie (2025) Vol. 150, Iss. 02, pp. 175-182
Closed Access
Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells
Florian Draguet, Nathan Dubois, C Bouland, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2901-2901
Open Access | Times Cited: 10
Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma
Kush Savsani, Sivanesan Dakshanamurthy
Diseases (2024) Vol. 12, Iss. 7, pp. 149-149
Open Access | Times Cited: 3
Polarization of Cancer-Associated Macrophages Maneuver Neoplastic Attributes of Pancreatic Ductal Adenocarcinoma
Huey‐Jen Lin, Yingguang Liu, Kailey Caroland, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3507-3507
Open Access | Times Cited: 6
Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
Manxiong Dai, Raja Jahanzaib, Yan Liao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Microsecond Molecular Dynamics Simulation to Gain Insight Into the Binding of MRTX1133 and Trametinib With KRASG12D Mutant Protein for Drug Repurposing
Ancy Iruthayaraj, Penislusshiyan Sakayanathan, Fuád Ameén, et al.
Journal of Molecular Recognition (2024)
Closed Access | Times Cited: 1
AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor
Komala Ingle, Joseph F. LaComb, Lee M. Graves, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294065-e0294065
Open Access | Times Cited: 3
Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 362-364
Open Access | Times Cited: 2
Targeted Degradation of KRASG12D as Potential Therapy in Cancer
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 537-538
Open Access | Times Cited: 2
Targeting KRASG12D Mutations: Discovery of Small Molecule Inhibitors for the Potential Treatment of Intractable Cancers
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 8, pp. 1041-1042
Closed Access | Times Cited: 2
The Mutation Portraits of Oncogenes and Tumor Supressor Genes in Predicting the Overall Survival in Pancreatic Cancer: A Bayesian Network Meta-Analysis
Citra Aryanti, Julianus Aboyaman Uwuratuw, Ibrahim Labeda, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 8, pp. 2895-2902
Open Access | Times Cited: 2
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
Andrea Vallés‐Martí, Richard R. de Goeij‐de Haas, Alex A. Henneman, et al.
Molecular Oncology (2024) Vol. 18, Iss. 8, pp. 2020-2041
Open Access
Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma.
Kush Savsani, Sivanesan Dakshanamurthy
(2024)
Open Access
Immune modulators for pancreatic ductal adenocarcinoma therapy
Rannah Dabiri, Mamoon Ur Rashid, Osama Sherjeel Khan, et al.
Elsevier eBooks (2024), pp. 103-129
Closed Access
Synchronous primary multiple cancer: distal cholangiocarcinoma of the intrapancreatic common bile duct and intraductal papillary mucinous tumor associated with ductal adenocarcinoma of the pancreatic tail
Galiya Setdikova, Е. А. Степанова, A. N. Verbovsky, et al.
Pirogov Russian Journal of Surgery (2024), Iss. 8, pp. 57-57
Closed Access
Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Cancer
Tereza Hálková, Bohuš Bunganič, Eva Traboulsi, et al.
Genes (2024) Vol. 15, Iss. 10, pp. 1302-1302
Open Access
Targeting the “Undruggable” Driver Protein, KRASG12D, as Potential Therapy in Prostate Cancer
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 365-366
Open Access | Times Cited: 1
Page 1

Scroll to top